// App-Quantinova.ai

924 : Highly-sensitive Cardiac Troponin-I and Beta-2-Glycoprotein-I IgA Antibodies Inform the Utility of Screening and Follow-up Non-invasive Coronary Atherosclerosis Evaluation and Optimize Cardiovascular Risk Assessment in Rheumatoid Arthritis

Researchers

Presenter

  • Sarah Ormseth

Principal Investigators

  • Elizabeth Hernandez

  • Matthew Budoff

Medical Centers

  • Harbor - UCLA Med Ctr and Los Angeles Biomedical Research Institute, Torrance, CA

  • Harbor - UCLA Med Ctr and Los Angeles Biomedical Research Institute, Torrance, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Coronary Artery Disease

  • Inflammatory Arthritis

Biomarkers

  • Carbonic anhydrase II

  • Troponin I

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved